XML 57 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Tables)
5 Months Ended
Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]  
Schedule of effects of restatements on previously issued financial statements
 

As
Previously Reported

 

Adjustments

 

As Restated

Balance sheet as of October 19, 2020 (audited)

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liabilities

 

$

 

 

$

5,157,000

 

 

$

5,157,000

 

Class A common stock subject to possible redemption

 

 

107,104,620

 

 

 

(5,157,000

)

 

 

101,947,620

 

Class A common stock

 

 

79

 

 

 

52

 

 

 

131

 

Additional paid-in capital

 

 

5,004,204

 

 

 

191,060

 

 

 

5,195,264

 

Accumulated deficit

 

 

(4,608

)

 

 

(191,112

)

 

 

(195,720

)

   

 

 

 

 

 

 

 

 

 

 

 

Balance sheet as of December 31, 2020 (audited)

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liabilities

 

$

 

 

$

9,040,670

 

 

$

9,040,670

 

Class A common stock subject to possible redemption

 

 

106,882,750

 

 

 

(9,040,670

)

 

 

97,842,080

 

Class A common stock

 

 

81

 

 

 

91

 

 

 

172

 

Additional paid-in capital

 

 

5,148,390

 

 

 

4,074,691

 

 

 

9,223,081

 

Accumulated deficit

 

 

(148,751

)

 

 

(4,074,782

)

 

 

(4,223,533

)

   

 

 

 

 

 

 

 

 

 

 

 

Statement of Operations for the period from August 11, 2020 (inception) to December 31, 2020 (audited)

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrant liabilities

 

$

 

 

$

3,883,670

 

 

$

3,883,670

 

Offering expense associated with warrant liabilities

 

 

 

 

 

191,112

 

 

 

191,112

 

Net loss

 

 

(148,751

)

 

 

(4,074,782

)

 

 

(4,223,533

)

Basic and diluted net loss per share, Class B common stock

 

 

(0.06

)

 

 

(1.42

)

 

 

(1.48

)

   

 

 

 

 

 

 

 

 

 

 

 

Statement of Cash Flows for the period from August 11, 2020 (inception) to December 31, 2020 (audited)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(148,751

)

 

$

(4,074,782

)

 

$

(4,223,533

)

Offering costs allocable to warrant liabilities

 

 

 

 

 

191,112

 

 

 

191,112

 

Change in fair value of warrant liabilities

 

 

 

 

 

3,883,670

 

 

 

3,883,670

 

Initial classification of Class A common shares subject to possible redemption

 

 

107,104,620

 

 

 

(5,157,000

)

 

 

101,947,620

 

Change in value of Class A common shares subject to possible redemption

 

 

(221,870

)

 

 

(3,883,670

)

 

 

(4,105,540

)

Balance sheet as of October 19, 2020 (audited)

 

As Previously
Restated and
Reported in
Form 10-K/A
Amendment
No. 1

 

Adjustments

 

As Restated

Total assets

 

$

116,390,976

 

 

 

 

 

$

116,390,976

 

Total liabilities

 

$

9,443,350

 

 

 

 

 

$

9,443,350

 

Class A common stock subject to possible redemption

 

 

101,947,620

 

 

 

13,052,380

 

 

 

115,000,000

 

Preferred stock

 

 

 

 

 

 

 

 

 

Class A common stock

 

 

131

 

 

 

(131

)

 

 

 

Class B common stock

 

 

331

 

 

 

 

 

 

331

 

Additional paid-in capital

 

 

5,195,264

 

 

 

(5,195,264

)

 

 

 

Accumulated deficit

 

 

(195,720

)

 

 

(7,856,985

)

 

 

(8,052,705

)

Total stockholders’ equity (deficit)

 

$

5,000,006

 

 

$

(13,052,380

)

 

$

(8,052,374

)

Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit)

 

$

116,390,976

 

 

$

 

 

$

116,390,976

 

Balance sheet as of December 31, 2020 (audited)

 

As Previously
Restated and
Reported in
Form 10-K/A
Amendment
No. 1

 

Adjustments

 

As Restated

Total assets

 

$

116,067,608

 

 

 

 

 

$

116,067,608

 

Total liabilities

 

$

13,225,520

 

 

 

 

 

$

13,225,520

 

Class A common stock subject to possible redemption

 

 

97,842,080

 

 

 

17,157,920

 

 

 

115,000,000

 

Preferred stock

 

 

 

 

 

 

 

 

 

Class A common stock

 

 

172

 

 

 

(172

)

 

 

 

Class B common stock

 

 

288

 

 

 

 

 

 

288

 

Additional paid-in capital

 

 

9,223,081

 

 

 

(9,223,081

)

 

 

 

Accumulated deficit

 

 

(4,223,533

)

 

 

(7,934,667

)

 

 

(12,158,200

)

Total stockholders’ equity (deficit)

 

$

5,000,008

 

 

$

(17,157,920

)

 

$

(12,157,912

)

Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit)

 

$

116,067,608

 

 

$

 

 

$

116,067,608

 

For the Period From August 11, 2020 (Inception) Through December 31, 2020

 

As Previously
Restated and
Reported in
Form 10-K/A
Amendment
No. 1

 

Adjustments

 

As Restated

Supplemental Disclosure of Noncash Financing Activities:

 

 

 

 

 

 

 

 

 

 

 

Initial value of Class A common stock subject to possible redemption

 

$

101,947,620

 

 

$

(101,947,620

)

 

$

Change in value of Class A common stock subject to possible redemption

 

$

(4,105,540

)

 

$

4,105,540

 

 

$

 

Net Loss Per Share

For the Period From August 11, 2020 (Inception) Through December 31, 2020

 

As Previously Restated and Reported in Form 10-K/A Amendment No. 1

 

Adjustments

 

As Restated

Net loss

 

$

(4,223,533

)

 

$

 

 

$

(4,223,533

)

Weighted average shares outstanding – Class A common stock

 

 

11,500,000

 

 

 

(5,588,028

)

 

 

5,911,972

 

Basic and diluted net loss per share – Class A common stock

 

$

0.00

 

 

$

(0.48

)

 

$

(0.48

)

Weighted average shares outstanding – Class B common stock

 

 

2,875,000

 

 

 

 

 

 

2,875,000

 

Basic and diluted net loss per share – Class B common stock

 

$

(1.48

)

 

$

1.00

 

 

$

(0.48

)